Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiazhen Cui

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|January 8, 2025
Optimizing Yeast Homologous Recombination for Splicing Large Coronavirus Genome FragmentsGuoqing Xiong, Xuan Huang, Ao Hu, et al.
Bone Marrow Transplantation|February 20, 2021
CRS-related coagulopathy in BCMA targeted CAR-T therapy: a retrospective analysis in a phase I/II clinical trialMi Shao, Qin Yu, Xinyi Teng, et al.
Frontiers in Microbiology|November 13, 2024
Monitoring of <i>Bacillus</i> spore-forming dynamics through flow cytometryZhili Chen, Yuanyuan Lu, Jiazhen Cui, et al.
Vaccines|April 23, 2025
Recombinant Detoxified Holotoxin as a Potent Candidate Vaccine Against BotulismZhixin Meng, Chunlin Cheng, Guoqing Xiong, et al.
Bone Marrow Transplantation|February 2, 2020
CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutationsAiyun Jin, Jingjing Feng, Guoqing Wei, et al.
Transplantation and Cellular Therapy|May 14, 2026
Long-Term Follow-Up of CD19 CAR-T for R/R B-NHL: Ki-67 as a Prognostic Factor for Sustained RemissionYinghui Yu, Wenxin Wang, Zhuomao Mo, et al.
Bone Marrow Transplantation|June 1, 2022
Predictive value of next-generation sequencing-based minimal residual disease after CAR-T cell therapyYue Huang, Houli Zhao, Mi Shao, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 7, 2021
BCMA CAR-T Therapy Is Safe and Effective for Refractory/Relapsed Multiple Myeloma With Central Nervous System InvolvementYiyun Wang, Cheng Zu, Xinyi Teng, et al.
Blood Cancer Journal|October 20, 2020
A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemiaYiyun Wang, Yingying Yang, Ruimin Hong, et al.
Cell Transplantation|September 5, 2023
HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell LymphomaXueer Xu, Cheng Zu, Mingming Zhang, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|January 8, 2025
Optimizing Yeast Homologous Recombination for Splicing Large Coronavirus Genome FragmentsGuoqing Xiong, Xuan Huang, Ao Hu, et al.
Bone Marrow Transplantation|February 20, 2021
CRS-related coagulopathy in BCMA targeted CAR-T therapy: a retrospective analysis in a phase I/II clinical trialMi Shao, Qin Yu, Xinyi Teng, et al.
Frontiers in Microbiology|November 13, 2024
Monitoring of <i>Bacillus</i> spore-forming dynamics through flow cytometryZhili Chen, Yuanyuan Lu, Jiazhen Cui, et al.
Vaccines|April 23, 2025
Recombinant Detoxified Holotoxin as a Potent Candidate Vaccine Against BotulismZhixin Meng, Chunlin Cheng, Guoqing Xiong, et al.
Bone Marrow Transplantation|February 2, 2020
CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutationsAiyun Jin, Jingjing Feng, Guoqing Wei, et al.
Transplantation and Cellular Therapy|May 14, 2026
Long-Term Follow-Up of CD19 CAR-T for R/R B-NHL: Ki-67 as a Prognostic Factor for Sustained RemissionYinghui Yu, Wenxin Wang, Zhuomao Mo, et al.
Bone Marrow Transplantation|June 1, 2022
Predictive value of next-generation sequencing-based minimal residual disease after CAR-T cell therapyYue Huang, Houli Zhao, Mi Shao, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 7, 2021
BCMA CAR-T Therapy Is Safe and Effective for Refractory/Relapsed Multiple Myeloma With Central Nervous System InvolvementYiyun Wang, Cheng Zu, Xinyi Teng, et al.
Blood Cancer Journal|October 20, 2020
A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemiaYiyun Wang, Yingying Yang, Ruimin Hong, et al.
Cell Transplantation|September 5, 2023
HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell LymphomaXueer Xu, Cheng Zu, Mingming Zhang, et al.
Pageof 6